Wals-Zurita A - Search Results

1

Implications of the Harmonization of [¹⁸F]FDG-PET/CT Imaging for Response Assessment of Treatment in Radiotherapy Planning.

Jiménez-Ortega E, Agüera R, Ureba A, Balcerzyk M, Wals-Zurita A, García-Gómez FJ, Leal A. Jiménez-Ortega E, et al. Among authors: wals zurita a. Tomography. 2022 Apr 12;8(2):1097-1112. doi: 10.3390/tomography8020090. Tomography. 2022. PMID: 35448724 Free PMC article.

2

Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy.

Jiménez-Ortega E, Ureba A, Baeza JA, Barbeiro AR, Balcerzyk M, Parrado-Gallego Á, Wals-Zurita A, García-Gómez FJ, Leal A. Jiménez-Ortega E, et al. Among authors: wals zurita a. PLoS One. 2019 Jan 9;14(1):e0210549. doi: 10.1371/journal.pone.0210549. eCollection 2019. PLoS One. 2019. PMID: 30625230 Free PMC article.

3

Dose painting by means of Monte Carlo treatment planning at the voxel level.

Jiménez-Ortega E, Ureba A, Vargas A, Baeza JA, Wals-Zurita A, García-Gómez FJ, Barbeiro AR, Leal A. Jiménez-Ortega E, et al. Among authors: wals zurita a. Phys Med. 2017 Oct;42:339-344. doi: 10.1016/j.ejmp.2017.04.005. Epub 2017 Apr 12. Phys Med. 2017. PMID: 28412136

4

Proposals of models for new formulations of the current complication-free cure (P+) and uncomplicated tumor control probability (UTCP) concepts, and total normal tissue complication probability of late complications.

Frometa-Castillo T, Pyakuryal A, Wals-Zurita A, Mesbahi A. Frometa-Castillo T, et al. Among authors: wals zurita a. Int J Radiat Biol. 2020 Jul;96(7):847-850. doi: 10.1080/09553002.2020.1741722. Epub 2020 Mar 31. Int J Radiat Biol. 2020. PMID: 32163306

5

The use of the normal tissue non-complication probability (NTCP0) in the safety evaluations as a new alternative of assessing the side-effects of the radiation oncology treatments.

Frometa-Castillo T, Pyakuryal A, Narayanasamy G, Wals-Zurita A, Mesbahi A. Frometa-Castillo T, et al. Among authors: wals zurita a. Int J Radiat Biol. 2023;99(4):656-662. doi: 10.1080/09553002.2022.2110299. Epub 2022 Aug 15. Int J Radiat Biol. 2023. PMID: 35930494

6

The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments.

Frometa-Castillo T, Pyakuryal A, Narayanasamy G, Mesbahi A, Wals-Zurita A. Frometa-Castillo T, et al. Among authors: wals zurita a. Rep Pract Oncol Radiother. 2022 Sep 19;27(4):602-609. doi: 10.5603/RPOR.a2022.0063. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36196423 Free PMC article.

7

External Beam Radiation Therapy: A Treatment Modality in Diffuse Tracheobronchial Amyloidosis.

Almadana Pacheco V, Luque Crespo E, Wals Zurita AJ, Montemayor Rubio T. Almadana Pacheco V, et al. Among authors: wals zurita aj. Arch Bronconeumol. 2015 Nov;51(11):607-8. doi: 10.1016/j.arbres.2015.05.004. Epub 2015 Jun 18. Arch Bronconeumol. 2015. PMID: 26093798 English, Spanish. No abstract available.

8

Spanish co-operative group of Medical Neuro-oncology (GENOM).

Contreras Martínez J, Azcoaga Blasco JM, Delgado Rico R, Wals Zurita A, Villanueva Alvarez A, Rivas Sánchez D, Herruzo Cabrera I. Contreras Martínez J, et al. Among authors: wals zurita a. Clin Transl Oncol. 2006 Oct;8(10):770. doi: 10.1007/s12094-006-0128-3. Clin Transl Oncol. 2006. PMID: 17074680 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page